← Leaderboards
Udaykumar Ranga
University Of Nebraska Medical Center
$1,296,777
Attributed
$3,890,331
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $838.8K · FY2016–20$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$3,890,331 · 1
By mechanism
R01$3,890,331 · 1
Top collaborators
- Shilpa J Buch5 shared
- Siddappa N Byrareddy5 shared
Most similar at University Of Nebraska Medical Center
Same institution · by research overlap
- Minglei Guo$7,203,802
- Huangui Hank Xiong$8,343,527
- Anuja Ghorpade$11,383,660
- Larisa Y Poluektova$9,010,153
- Sowmya Yelamanchili$4,184,204
Others in their field
Top investigators on “Acquired Immunodeficiency Syndrome”
- David Heimbrook · Leidos Biomedical Research, Inc.$300,790,583
- George R Seage · Abt Associates, Inc.$244,444,207
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$180,045,219
- Barbara Driver · Westat, Inc.$168,632,670
- Michelle Vargas · Ppd Development Lp$163,846,102
- Judith S. Currier · University Of California Los Angeles$150,146,659
Research focus
Acquired Immunodeficiency SyndromeAnimal ModelAnimalsAstrocytesAttenuationBaseBinding SitesBiologicalBrazilCd4 Lymphocyte CountCell LineCell Mediated Immune ResponseCentral Nervous System DiseasesChinaCombinatorialComorbidityCompetenceCountryCoupledDisease ManagementDisease ProgressionDrug AbuseDrug AbuserDrug Usage
Grant awards (5)
The combinatorial effects of Opiates and the emerging promoter-variant strains of HIV-1 subtype C on HIV neuropathogensis and latency$718,779
R01 · FY2020 · DA
The combinatorial effects of Opiates and the emerging promoter-variant strains of HIV-1 subtype C on HIV neuropathogensis and latency$757,800
R01 · FY2019 · DA
The combinatorial effects of Opiates and the emerging promoter-variant strains of HIV-1 subtype C on HIV neuropathogensis and latency$830,071
R01 · FY2018 · DA
The combinatorial effects of Opiates and the emerging promoter-variant strains of HIV-1 subtype C on HIV neuropathogensis and latency$838,842
R01 · FY2017 · DA
The combinatorial effects of Opiates and the emerging promoter-variant strains of HIV-1 subtype C on HIV neuropathogensis and latency$744,839
R01 · FY2016 · DA